ANIK
NASDAQ
$14.41
Anika Therapeutics Inc (ANIK)
Anika Therapeutics, Inc., is a joint preservation company in the United States, Europe, and internationally. The company is headquartered in Bedford, Massachusetts.
Sector:
Healthcare
Target: $17.50 (+21.44%)
Market Cap
$198M
Free Cash Flow Yield
0.53%
Beta (5Y)
0.91
Price Chart
Valuation
Market Cap$198M
Forward P/E35.46
PEG3.61
P/S1.70
P/B1.47
Profitability
Total Revenue (TTM)$116M
Gross Profit (TTM)$68M
EBITDA-$6.86M
Profit Margin-17.1%
Operating Margin-18.5%
EPS-$0.79
Financial Health
Free Cash Flow Yield0.53%
Growth & Risk
EPS 5Y CAGR-15.91%
Revenue 5Y CAGR-2.11%
FCF 5Y CAGR-33.95%
Beta (5Y)0.91
Sharpe Ratio0.68